Results 141 to 150 of about 587 (195)
Some of the next articles are maybe not open access.

Adjuvanticity and Arthritogenicity of Silicone

Plastic and Reconstructive Surgery, 1993
Potential adjuvanticity and arthritogenicity of silicone obtained from a mammary implant were investigated. Silicone, injected intraperitoneally in conjunction with heat-killed Mycobacterium tuberculosis and EL4 cells (mouse tumor cell, H-2b), failed to enhance the development of immune response directed toward EL4 cells in Lewis rats.
openaire   +2 more sources

What are the limits of adjuvanticity?

Vaccine, 2001
Vaccines developed traditionally following empirical approaches have often limited problems of immunogenicity, probably due to the low level of purity of the active component(s) they contain. The application of new technologies to vaccine development is leading to the production of purer (e.g. recombinant) antigens which, however, tend to have a poorer
G, Del Giudice, A, Podda, R, Rappuoli
openaire   +2 more sources

Adjuvante dermatokosmetische Aknetherapie

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2010
Adjuvant dermato-cosmetic therapy in acne is an essential part of the concept of treating acne after initiation and during maintenance therapy. Those are mechanical peeling, chemical peeling and its combination. It needs supervision by an experienced dermatologist.
Christiane Bayerl   +3 more
openaire   +1 more source

How is Adjuvanticity Recognised?

1983
The activities of the immune system are customarily divided into specific functions mediated by immunoglobulin, and a range of other functions which are loosely classed by “non-specific”. Many of these latter do however exhibit a degree of specificity.
R. B. Taylor, C. A. Morrison
openaire   +1 more source

Adjuvante systemische Therapie

2006
Eine grosere Anzahl von einzelnen Studien, insbesondere aber die Metaanalyse der „Early Breast Cancer Trialist’s Collaborative Group“ (EB-CTCG), haben den Nutzen einer Chemo- und Hormontherapie in der adjuvanten Behandlung des Mammakarzinomes eindrucksvoll bewiesen.
Volker Möbus   +4 more
openaire   +1 more source

The adjuvanticity of interleukin 1 in vivo.

The Journal of Immunology, 1983
Abstract Interleukin 1 (IL 1) was shown to enhance in vivo secondary antibody responses of mice to a protein antigen. The activity was found to be dose and time dependent. The maximum enhancing effect was obtained with 2000 LAF units of IL 1 given 2 hr after the priming dose of antigen.
M J, Staruch, D D, Wood
openaire   +2 more sources

Triggering Intracellular Receptors for Vaccine Adjuvantation

Trends in Immunology, 2016
Immune adjuvants are components that stimulate, potentiate, or modulate the immune response to an antigen. They are key elements of vaccines in both the prophylactic and therapeutic domains. In the past decade substantial progress in our understanding of innate immunity has paved the way for the design of next-generation adjuvants that stimulate a wide
Alice Gutjahr   +4 more
openaire   +3 more sources

Surface hydrophobicity of microparticles modulates adjuvanticity

Journal of Materials Chemistry B, 2013
Polymeric microparticles are promising adjuvants and they exhibit various physicochemical characteristics that can regulate the immune response, including hydrodynamic size, morphology, and surface properties, among others. Surface hydrophobicity is also a key microparticle characteristic, but how it affects microparticle adjuvanticity remains unknown.
Yuan, Liu   +7 more
openaire   +2 more sources

Bronchialkarzinom — adjuvante Chemotherapie

1990
Die schlechte Spatprognose der Patienten mit Bronchialkarzinomen spricht fur den Einsatz einer adjuvanten Chemotherapie. Wegen ihrer nicht bewiesenen Wirkung ist sie beim nicht-kleinzelligen Bronchialkarzinom gegenwartig jedoch nur innerhalb klinischer Studien gerechtfertigt. Beim kleinzelligen Bronchialkarzinom dominiert die Chemotherapie.
openaire   +1 more source

Mechanisms of vaccine adjuvanticity at mucosal surfaces

Animal Health Research Reviews, 2000
AbstractThe vast majority of pathogens invade via mucosal surfaces, including those of the intestine. Vaccination directly on these surfaces may induce local protective immunity and prevent infection and disease. Although vaccine delivery to the gut mucosa is fraught with obstacles, immunization can be enhanced using adjuvants with properties specific ...
D L, Foss, M P, Murtaugh
openaire   +2 more sources

Home - About - Disclaimer - Privacy